Clinical Trials Browser

Phase 1/2 × Pancreatic Ductal Adenocarcinoma × Clear all

NCT04827953 2024-12-30

NUMANTIA

Phase 1/2 Active not recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma